McMaster University

McMaster University

Medical Oncology

A Message from the Division Head, Medical Oncology

Dr. Peter Ellis, Division Head, Medical Oncology
Professor, Department of Oncology, McMaster University

The Division of Medical Oncology provides innovative and state-of-the-art treatment for patients with solid malignancies. There are currently 26 full and part-time faculty members in the division.

As part of the academic Department of Oncology, our commitment to education is at the heart of the mission of the Faculty of Health Sciences, McMaster University. The introduction of oncology through its Medical Foundation Program to the undergraduate medical curriculum is unique as it promotes an understanding of basic science in the context of clinical oncology. This acts as a translational tool that prepares students for developing the required knowledge and skill sets for therapeutic decision-making in their future careers. Our postgraduate program in medical oncology provides two years of training based at the Juravinski Cancer Centre which is one of the largest cancer care facilities in North America. The program is divided into 12 months of general medical oncology, 3 months each of radiation oncology and malignant haematology, 1 month of palliative care and 5 months of electives/selective clinics.  Residents participate in regular tumour boards, academic half days, and journal clubs. They are also encouraged to participate in a research project. We offer post-residency research training in early drug development, clinical research methodology in breast cancer and other disease sites. Our clinics serve as a very fertile educational experience for medical and nursing students.

Our commitment to clinical research and evidence-based care is a particular strength that we are proud of. Many of our faculty are graduates of the Health Research Methodology Program in the Faculty of Health Sciences and are very active in clinical trials. This involves the design of studies, recruitment of patients and analysis of results. Clinical trials are important because they help develop new knowledge which is of benefit to patients, and provide patients the opportunity to receive treatments that are not otherwise available at other centres. We are members of the National Cancer Institute of Canada Clinical Trials Group, the Ontario Clinical Oncology Group, and the Princess Margaret Consortium.  Research into the assessment of clinical trial outcomes and the development of Cancer Care Ontario clinical practice guidelines is a priority of the division.


Key Contacts

Dr. Peter Ellis
Division Head, Medical Oncology
905-387-9711 x64609
Email:ellisp@hhsc.ca

 

Avril Rogers
Administrative Supervisor
Division of Medical Oncology
Phone: 905-387-9711, Ext. 67658
Fax:     905-575-6326
Email:rogeravr@hhsc.ca

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0